bioAffinity Technologies Files S-1 for Public Offering

Ticker: BIAFW · Form: S-1 · Filed: May 2, 2025 · CIK: 1712762

Sentiment: neutral

Topics: s-1, public-offering, biotech

TL;DR

bioAffinity Technologies files S-1, looks to raise cash via public offering.

AI Summary

bioAffinity Technologies, Inc. filed an S-1 form on May 2, 2025, indicating a public offering. The company, based in San Antonio, TX, is involved in commercial physical and biological research. This filing suggests they are seeking to raise capital through the sale of securities.

Why It Matters

This S-1 filing signals bioAffinity Technologies' intention to go public or raise additional funds, which could impact its growth trajectory and the competitive landscape in biological research.

Risk Assessment

Risk Level: medium — As an S-1 filing, it indicates a company seeking public investment, which inherently carries risks associated with market volatility and the company's specific business prospects.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this S-1 filing for bioAffinity Technologies, Inc.?

The S-1 filing indicates bioAffinity Technologies, Inc.'s intention to register securities for a public offering, likely to raise capital.

When was this S-1 filing submitted to the SEC?

The S-1 filing was submitted on May 2, 2025.

Where is bioAffinity Technologies, Inc. located?

bioAffinity Technologies, Inc. is located at 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX 78217.

What is the Standard Industrial Classification (SIC) code for bioAffinity Technologies, Inc.?

The SIC code is 8731, which falls under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.

What is the SEC file number associated with this S-1 filing?

The SEC file number is 333-286921.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on May 2, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing